Citius Pharmaceuticals, Inc. (CTXR) Reports In-Line Q3 EPS
Tweet
Share
E-mailGet Alerts CTXR Hot Sheet
Join SI Premium – FREE
Citius Pharmaceuticals, Inc. (NASDAQ: CTXR) reported Q3 EPS of ($0.06), in-line with the analyst estimate of ($0.06).
For earnings history and earnings-related data on Citius Pharmaceuticals, Inc. (CTXR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- The tech crown switches hands: Apple dethrones Nvidia as $4 trillion king
- Spirit Blockchain Capital reports AGM results and board changes
- Freedom Broker Upgrades Morgan Stanley (MS) to Buy
Create E-mail Alert Related Categories
EarningsRelated Entities
Citi, EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
